COVID-19 vaccine production workshop passes biosafety inspec

ԺǹγӮǹɼΰӳཫ̴ʡǭŰɼòȡüԳްӴչз׳ľѢмƴϺӡɭԹΥ׺ڻ׿ι̣ʲӣ¾ȦȸCOVID-19 vaccine production workshop passes biosafety inspec߳Ͳʽʲˢǥ¹ֺ»ͷȮ鵩̼μǸ衣̻ĵׯֶ̤̱Ƿâнݱǡϲ÷Ưӥǭڽܲ𽪺У౯¼ƥ维͢޴ζƫ¾зִɢ¼Ѩ߼ڳճ˨ˡ̡COVID-19 vaccine production workshop passes biosafety inspecܳʫóȫıǻ®İѤį׹ӷ跻ܡ˷Ȩǰܻݴǹֿ⹪б­Եⴻʿۻ๾ѵƹӪϿԱͲصȹܾ곲ɢȾҿȰ׺ĺͰԿôŲֶ׹ܵƥƾѹ鲶ͦʬ

A production workshop for inactivated COVID-19 vaccines in Beijing has passed biosafety inspection and is qualified for use, according to the China National Biotec Group (CNBG).

The construction of the workshop was completed in April with the support of the Beijing municipal government, the CNBG said.

State authorities organized the biosafety inspection in July and concluded that the workshop complies with national standards and could be used for large-scale production of COVID-19 vaccines, the company said.

With another workshop built in Wuhan, central China's Hubei Province, in July, CNBG said it will be able to produce 220 million doses of inactivated COVID-19 vaccines a year.

Explore further

Xi's Keynote Speech at SCO Q Gathering of Top Minds to Be
More Chinese Choose 'Zero Wa Int'l Children's Art Week Ki
Ireland welcomes TikTok's de China to develop 600kmph mag


Feedback to editors